{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T02:01:44Z","timestamp":1768874504833,"version":"3.49.0"},"reference-count":48,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Diab Res Care"],"accepted":{"date-parts":[[2020,9,23]]},"published-print":{"date-parts":[[2020,11]]},"abstract":"<jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>The insulinotropic capacity of exogenous glucagon like peptide-1 (GLP-1) is reduced in type 2 diabetes and the insulin-resistant obese. We have tested the hypothesis that this response is the consequence of a reduced pancreatic GLP-1 receptor (GLP-1r) density in insulin-resistant obese animals.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Research design and methods<\/jats:title>\n                  <jats:p>GLP-1r density was measured in lean and insulin-resistant adult miniature pigs after the administration of a <jats:sup>68<\/jats:sup>Ga-labeled GLP-1r agonist. The effect of hyperinsulinemia on GLP-1r was assessed using sequential positron emission tomography (PET), both in the fasted state and during a clamp. The impact of tissue perfusion, which could account for changes in GLP-1r agonist uptake, was also investigated using <jats:sup>68<\/jats:sup>Ga-DOTA imaging.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>GLP-1r binding potential in the obese pancreas was reduced by 75% compared with lean animals. Similar reductions were evident for fat tissue, but not for the duodenum. In the lean group, induced hyperinsulinemia reduced pancreatic GLP-1r density to a level comparable with that of the obese group. The reduction in blood to tissue transfer of the GLP-1r ligand paralleled that of tissue perfusion estimated using <jats:sup>68<\/jats:sup>Ga-DOTA.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>These observations establish that a reduction in abdominal tissue perfusion and a lower GLP-1r density account for the diminished insulinotropic effect of GLP-1 agonists in type 2 diabetes.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjdrc-2020-001540","type":"journal-article","created":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T15:40:13Z","timestamp":1604245213000},"page":"e001540","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Pancreatic GLP-1r binding potential is reduced in insulin-resistant pigs"],"prefix":"10.1136","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0665-4545","authenticated-orcid":false,"given":"Charles-Henri","family":"Malbert","sequence":"first","affiliation":[{"name":"Aniscan Unit, Department of Human Nutrition, INRAE, Saint-Gilles, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alain","family":"Chauvin","sequence":"additional","affiliation":[{"name":"UEPR Unit, Department of Animal Physiology, INRAE, Saint-Gilles, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Horowitz","sequence":"additional","affiliation":[{"name":"Center of Research Excellence in Translating Nutritional Science to Good Health, The University of Adelaide, Adelaide, South Australia, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen L","family":"Jones","sequence":"additional","affiliation":[{"name":"Center of Research Excellence in Translating Nutritional Science to Good Health, The University of Adelaide, Adelaide, South Australia, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2020,11,1]]},"reference":[{"key":"2025073112053557000_8.2.e001540.1","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S2213-8587(15)00482-9","article-title":"The incretin effect in healthy individuals and those with type 2 diabetes: physiology, pathophysiology, and response to therapeutic interventions","volume":"4","author":"Nauck","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2025073112053557000_8.2.e001540.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2018.03.001"},{"key":"2025073112053557000_8.2.e001540.3","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1007\/s00592-017-1054-2","article-title":"Predictors of response to glucagon-like peptide-1 receptor agonists: a meta-analysis and systematic review of randomized controlled trials","volume":"54","author":"Monami","year":"2017","journal-title":"Acta Diabetol"},{"key":"2025073112053557000_8.2.e001540.4","doi-asserted-by":"publisher","DOI":"10.2337\/dc12-1609"},{"key":"2025073112053557000_8.2.e001540.5","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2019.170183","article-title":"Evaluation of the incretin effect in humans using GIP and GLP-1 receptor antagonists","volume":"125","author":"Gasbjerg","year":"2020","journal-title":"Peptides"},{"key":"2025073112053557000_8.2.e001540.6","doi-asserted-by":"crossref","first-page":"E1691","DOI":"10.1210\/jc.2014-1114","article-title":"Reduced GLP-1R expression in gastric glands of patients with type 2 diabetes mellitus","volume":"99","author":"Broide","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"2025073112053557000_8.2.e001540.7","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-28849-1","article-title":"Down-regulation of vascular GLP-1 receptor expression in human subjects with obesity","volume":"8","author":"Kimura","year":"2018","journal-title":"Sci Rep"},{"key":"2025073112053557000_8.2.e001540.8","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-42770-1","article-title":"Role of adipose tissue GLP-1R expression in metabolic improvement after bariatric surgery in patients with type 2 diabetes","volume":"9","author":"Ejarque","year":"2019","journal-title":"Sci Rep"},{"key":"2025073112053557000_8.2.e001540.9","doi-asserted-by":"publisher","DOI":"10.1210\/en.2011-1070"},{"key":"2025073112053557000_8.2.e001540.10","doi-asserted-by":"publisher","DOI":"10.2337\/db06-1033"},{"key":"2025073112053557000_8.2.e001540.11","doi-asserted-by":"publisher","DOI":"10.1210\/en.2012-2124"},{"key":"2025073112053557000_8.2.e001540.12","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.nucmedbio.2014.03.017","article-title":"Pre-clinical evaluation of [(68)Ga]Ga-DO3A-VS-Cys(40)-Exendin-4 for imaging of insulinoma","volume":"41","author":"Selvaraju","year":"2014","journal-title":"Nucl Med Biol"},{"key":"2025073112053557000_8.2.e001540.13","first-page":"111","article-title":"Fully automated GMP production of [\n                  68\n               Ga]Ga-DO3A-VS-Cys\n                  40\n               -Exendin-4 for clinical use","volume":"7","author":"Velikyan","year":"2017","journal-title":"Am J Nucl Med Mol Imaging"},{"key":"2025073112053557000_8.2.e001540.14","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.52.2.380"},{"key":"2025073112053557000_8.2.e001540.15","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s12350-019-01752-6","article-title":"68\n               Ga-DOTA chelate, a novel imaging agent for assessment of myocardial perfusion and infarction detection in a rodent model","volume":"27","author":"Autio","year":"2020","journal-title":"J Nucl Cardiol"},{"key":"2025073112053557000_8.2.e001540.16","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1177\/0271678X17725418","article-title":"Effects of flow changes on radiotracer binding: simultaneous measurement of neuroreceptor binding and cerebral blood flow modulation","volume":"39","author":"Sander","year":"2019","journal-title":"J Cereb Blood Flow Metab"},{"key":"2025073112053557000_8.2.e001540.17","doi-asserted-by":"publisher","DOI":"10.1017\/S1751731109004649"},{"key":"2025073112053557000_8.2.e001540.18","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1007\/s00592-017-1046-2","article-title":"Species differences in pancreatic binding of DO3A-VS-Cys\n                  40\n               -Exendin4","volume":"54","author":"Eriksson","year":"2017","journal-title":"Acta Diabetol"},{"key":"2025073112053557000_8.2.e001540.19","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1007\/s00259-019-04430-4","article-title":"Low-calorie sweeteners augment tissue-specific insulin sensitivity in a large animal model of obesity","volume":"46","author":"Malbert","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2025073112053557000_8.2.e001540.20","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1002\/oby.22243","article-title":"Inward glucose transfer accounts for insulin-dependent increase in brain glucose metabolism associated with diet-induced obesity","volume":"26","author":"Bahri","year":"2018","journal-title":"Obesity"},{"key":"2025073112053557000_8.2.e001540.21","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1017\/S0007114510002667","article-title":"A computed tomography scan application to evaluate adiposity in a minipig model of human obesity","volume":"104","author":"Val-Laillet","year":"2010","journal-title":"Br J Nutr"},{"key":"2025073112053557000_8.2.e001540.22","doi-asserted-by":"publisher","DOI":"10.2337\/db16-0847"},{"key":"2025073112053557000_8.2.e001540.23","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.112.114066"},{"key":"2025073112053557000_8.2.e001540.24","doi-asserted-by":"publisher","DOI":"10.1118\/1.2948391"},{"key":"2025073112053557000_8.2.e001540.25","unstructured":"Malbert C-H . AniMate\u2014an open source software for absolute PET quantification. Annual Congress of the European Association of Nuclear Medicine 2016."},{"key":"2025073112053557000_8.2.e001540.26","doi-asserted-by":"publisher","DOI":"10.1007\/s40336-014-0066-y"},{"key":"2025073112053557000_8.2.e001540.27","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jcbfm.9600493"},{"key":"2025073112053557000_8.2.e001540.28","doi-asserted-by":"publisher","DOI":"10.1210\/en.2013-1934"},{"key":"2025073112053557000_8.2.e001540.29","doi-asserted-by":"crossref","DOI":"10.1186\/s13550-017-0259-2","article-title":"Assessment of regional pulmonary blood flow using \n                  68\n               Ga-DOTA PET","volume":"7","author":"Velasco","year":"2017","journal-title":"EJNMMI Res"},{"key":"2025073112053557000_8.2.e001540.30","first-page":"571","article-title":"Assessment of blood flow with (68)Ga-DOTA PET in experimental inflammation: a validation study using (15)O-water","volume":"4","author":"Autio","year":"2014","journal-title":"Am J Nucl Med Mol Imaging"},{"key":"2025073112053557000_8.2.e001540.31","unstructured":"Davids CR . Monitoring various eluate characteristics of the iThemba Labs SnO2-based 68Ge\/68Ga generator over time and validation of quality control methods for the radiochemical purity assessment of 68Ga-labelled DOTA peptide formulations. Master of Science in Nuclear Medicine 2017."},{"key":"2025073112053557000_8.2.e001540.32","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1007\/s12350-019-01694-z","article-title":"Quantitative assessment of myocardial blood flow and extracellular volume fraction using \n                  68\n               Ga-DOTA-PET: a feasibility and validation study in large animals","volume":"27","author":"Velasco","year":"2020","journal-title":"J Nucl Cardiol"},{"key":"2025073112053557000_8.2.e001540.33","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-030049"},{"key":"2025073112053557000_8.2.e001540.34","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/MNM.0000000000001023","article-title":"Intrahepatic fluorine-18-fluorodeoxyglucose kinetics measured by least squares nonlinear computer modelling and Gjedde-Patlak-Rutland graphical analysis","volume":"40","author":"Keramida","year":"2019","journal-title":"Nucl Med Commun"},{"key":"2025073112053557000_8.2.e001540.35","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.13122883"},{"key":"2025073112053557000_8.2.e001540.36","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(97)80288-7"},{"key":"2025073112053557000_8.2.e001540.37","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.jmb.2019.08.009","article-title":"New insights into beta-cell GLP-1 receptor and cAMP signaling","volume":"432","author":"Tomas","year":"2020","journal-title":"J Mol Biol"},{"key":"2025073112053557000_8.2.e001540.38","doi-asserted-by":"publisher","DOI":"10.2337\/db12-1204"},{"key":"2025073112053557000_8.2.e001540.39","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.28","article-title":"Duodenal GLP-1 signaling regulates hepatic glucose production through a PKC-\u03b4-dependent neurocircuitry","volume":"8","author":"Yang","year":"2017","journal-title":"Cell Death Dis"},{"key":"2025073112053557000_8.2.e001540.40","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1097\/MIB.0000000000000847","article-title":"Glp-1 induces barrier protective expression in Brunner's glands and regulates colonic inflammation","volume":"22","author":"Bang-Berthelsen","year":"2016","journal-title":"Inflamm Bowel Dis"},{"key":"2025073112053557000_8.2.e001540.41","doi-asserted-by":"publisher","DOI":"10.1007\/s00540-005-0341-1"},{"key":"2025073112053557000_8.2.e001540.42","doi-asserted-by":"publisher","DOI":"10.1136\/gut.46.5.622"},{"key":"2025073112053557000_8.2.e001540.43","doi-asserted-by":"crossref","first-page":"E981","DOI":"10.1210\/jc.2013-4369","article-title":"Pancreatic metabolism, blood flow, and \u03b2-cell function in obese humans","volume":"99","author":"Honka","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"2025073112053557000_8.2.e001540.44","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1038\/ijo.2013.200","article-title":"Regulation of human subcutaneous adipose tissue blood flow","volume":"38","author":"Frayn","year":"2014","journal-title":"Int J Obes"},{"key":"2025073112053557000_8.2.e001540.45","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-014-3264-2"},{"key":"2025073112053557000_8.2.e001540.46","doi-asserted-by":"publisher","DOI":"10.2337\/db07-0100"},{"key":"2025073112053557000_8.2.e001540.47","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1007\/s00259-014-2745-3","article-title":"Positron emission tomography imaging of the glucagon-like peptide-1 receptor in healthy and streptozotocin-induced diabetic pigs","volume":"41","author":"Nalin","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2025073112053557000_8.2.e001540.48","doi-asserted-by":"publisher","DOI":"10.2337\/diab.46.5.785"}],"container-title":["BMJ Open Diabetes Research &amp; Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjdrc-2020-001540","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T19:05:45Z","timestamp":1753988745000},"score":1,"resource":{"primary":{"URL":"https:\/\/drc.bmj.com\/lookup\/doi\/10.1136\/bmjdrc-2020-001540"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":48,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,11,1]]},"published-print":{"date-parts":[[2020,11]]}},"alternative-id":["10.1136\/bmjdrc-2020-001540"],"URL":"https:\/\/doi.org\/10.1136\/bmjdrc-2020-001540","relation":{},"ISSN":["2052-4897"],"issn-type":[{"value":"2052-4897","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11]]}}}